Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-17

Clinical Trial Update: OM 85 to Prevent Respiratory Infections in Older At Risk Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on using OM-85 to prevent respiratory tract infections in older at-risk adults; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OM-85

Snippet

Sponsor: Fondazione Policlinico Universitario Campus Bio-Medico | Conditions: Respiratory Tract Infections (RTI) | Phase 4 | Status: ACTIVE_NOT_RECRUITING